36|7160|Public
40|$|Background: MicroRNAs (miRNAs) are small, noncoding oligonucleotides with an {{important}} role in posttranscriptional regulation of gene expression at the level of translation and mRNA degradation. Recent studies have revealed that miRNAs play important roles in a variety of biological processes, such as cell proliferation, neuronal differentiation, developmental timing, synapse function, and neurogenesis. A single miRNA can target hundreds of mRNA transcripts for either translation <b>repression</b> <b>or</b> <b>degradation,</b> but the function of many human miRNAs is not known...|$|E
40|$|Electrochemical genosensors {{have held}} great promise as devices {{suitable}} for point-of-care diagnostics and multiplexed platforms for fast, simple and inexpensive nucleic acid analysis. MicroRNA (miRNA), regulating gene expression by translational <b>repression</b> <b>or</b> <b>degradation</b> of messenger RNA, {{is believed to}} be important for cancer diagnosis and prognosis serving as a reliable molecular biomarker. In recent years, there have been many attempts for miRNA detection using electrochemical genesensors. In this work, we first addressed the progress in designing of miRNA detection strategies based on the difference in the structure of RNA and DNA. This work should be valuable for the design of new types of miRNA genesensors...|$|E
40|$|MicroRNAs (miRNAs) {{are small}} RNAs {{comprised}} of 20 – 25 nucleotides that regulates gene expression by inducing translational <b>repression</b> <b>or</b> <b>degradation</b> of target mRNA. The importance of miRNAs {{as a mediator}} of disease pathogenesis and therapeutic targets is rapidly emerging in neuroscience, as well as oncology, immunology, and cardiovascular diseases. In Parkinson’s disease and related disorders, multiple studies have identified the implications of specific miRNAs and the polymorphisms of miRNA target genes during the disease pathogenesis. With a focus on Parkinson’s disease, spinocerebellar ataxia, hereditary spastic paraplegia, and Huntington’s disease, this review summarizes and interprets the observations, and proposes future research topics in this field...|$|E
40|$|AbstractMicroRNAs (miRNAs) are short, noncoding RNAs {{that act}} as key {{regulators}} of diverse biological processes by mediating translational <b>repression</b> <b>or</b> mRNA <b>degradation</b> of target genes. Recent studies discovered miRNAs in saliva, and these miRNAs are promising candidates for use as biomarkers of dental diseases. In this review, the results of miRNA studies in the dental field are presented, and {{a brief overview of}} the current progress, limitations, and perspectives regarding miRNA biomarkers for dental diseases is given...|$|R
40|$|MicroRNAs (miRNAs) are a {{class of}} small RNAs (18 – 22 nt) that post transcriptionally {{regulate}} gene expression by binding to complementary sequences on target mRNAs, resulting in translational <b>repression</b> <b>or</b> target <b>degradation</b> and gene silencing. As aberrant expression of miRNAs is implicated in important diseases including cancer miRNA-based therapies are under intensive investigation. We optimized strategies to stably or conditionally generate miRNA inhibitors for a continuous block of miRNA activity that allows for probing miRNA function in long-term cell culture experiments, cancer xenografts, 3 D tissue models and for in vivo studies with transgenic organisms...|$|R
40|$|MicroRNAs {{are small}} endogenously {{expressed}} non-coding RNA molecules that regulate target gene expression through translation <b>repression</b> <b>or</b> messenger RNA <b>degradation.</b> MicroRNA regulation is performed through pairing of the microRNA to {{sites in the}} messenger RNA of protein coding genes. Since experimental identification of miRNA target genes poses difficulties, computational microRNA target prediction {{is one of the}} key means in deciphering the role of microRNAs in development and diseas...|$|R
40|$|Copyright © 2013 Kuijie Liu et al. This is an {{open access}} article {{distributed}} under theCreativeCommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MicroRNAs are a class of small, noncoding RNAs that function as critical regulators of gene expression by targeting mRNAs for translational <b>repression</b> <b>or</b> <b>degradation.</b> In this study, we demonstrate that expression of microRNA- 124 (miR- 124) is significantly downregulated in colorectal cancer tissues and cell lines, compared to the matched adjacent tissues. We identified and confirmed inhibitor of apoptosis-stimulating protein of p 53 (iASPP) as a novel, direct target of miR- 124 using target prediction algorithms and luciferase reporter gene assays. Overexpression of miR- 124 suppressed iASPP protein expression, upregulated expression of the downstream signaling molecule nuclear factor-kappa B (NF...|$|E
40|$|The {{authors have}} no {{financial}} conflicts of interest. Copyright © 2011 The Korean Movement Disorder Society 55 MicroRNAs (miRNAs) are small RNAs comprised of 20 - 25 nucleotides that regulates gene expression by inducing translational <b>repression</b> <b>or</b> <b>degradation</b> of target mRNA. The impor-tance of miRNAs {{as a mediator}} of disease pathogenesis and therapeutic targets is rapidly emerging in neuroscience, as well as oncology, immunology, and cardiovascular diseases. In Parkinson’s disease and related disorders, multiple studies have identified the implications of specific miRNAs and the polymorphisms of miRNA target genes during the disease pathogen-esis. With a focus on Parkinson’s disease, spinocerebellar ataxia, hereditary spastic paraplegia, and Huntington’s disease, this review summarizes and interprets the observations, and propos-es future research topics in this field. Journal of Movement Disorders 2011; 4 : 55 - 5...|$|E
40|$|MicroRNAs (miRNAs) are {{a growing}} class of {{evolutionarily}} conserved small non-coding RNAs {{that act as}} key regulators of gene expression at post-transcriptional level by targeting mRNAs for translational <b>repression</b> <b>or</b> <b>degradation.</b> These tiny regulators of gene expression {{have been shown to}} have unique tissue-specific, developmental stage-specific and disease-specific patterns. These observations suggest that miRNAs might be essential players in cell differentiation and maintenance of tissue type identity. Indeed, during the last years several studies highlighted that miRNAs {{play a critical role in}} the differentiation and function of the adaptive and innate immune systems. This review provides an overview of the miRNAs mode of action and of the important and diverse roles of miRNAs in regulating the development of hematopoietic system and in modulating immune responses. The implications arising in the field of autoimmune diseases will be discussed...|$|E
40|$|MicroRNAs (miRNAs) are a {{class of}} short, endogenously-initiated non-coding RNAs that post-transcriptionally control gene {{expression}} via either translational <b>repression</b> <b>or</b> mRNA <b>degradation.</b> It is becoming evident that miRNAs are playing significant roles in regulatory mechanisms operating in various organisms, including developmental timing and host-pathogen interactions as well as cell differentiation, proliferation, apoptosis and tumorigenesis. Likewise, as a regulatory element, miRNA itself is coordinatively modulated by multifarious effectors when carrying out basic functions, such as SNP, miRNA editing, methylation and circadian clock. This mini-review summarized the current understanding of interactions between miRNAs and their targets, including recent advancements in deciphering the regulatory mechanisms that control the biogenesis and functionality of miRNAs in various cellular processes...|$|R
40|$|MicroRNAs (MiRNAs) {{are highly}} conserved, non-protein-coding, {{approximately}} 18 - 24 nucleotides, small RNA molecules. These non-protein-coding RNAs bind target mRNAs which are complementary with their squences and post-transcriptionally regulate gene expression through translation <b>repression</b> <b>or</b> mRNA <b>degradation.</b> Using this pathway, miRNAs play {{important roles in}} homeostatic process including cell proliferation, differentiation and cell death. Recent studies based on gene expression have revealed that miRNA expressions are deregulated in cancer cells which have uncontrolled grow. According to character of target mRNA, miRNAs act like tumor supressor or oncogene in cancer initiation and progression. In this review, miRNA biogenesis and their roles in cancer progression are described and studies setting out the relationship between miRNAs and cancer are reviewed...|$|R
40|$|AbstractMicroRNAs (miRNAs) are a kind {{of small}} single-strand RNA {{molecules}} with lengths of 18 – 25 nt, which do not encode any proteins. They play an essential role in gene expression regulation by binding to their target genes, leading to translational <b>repression</b> <b>or</b> transcript <b>degradation.</b> In this study, 23 miRNAs were predicted from five cyprinidae fishes by using a bioinformatics-based gene search based on blasting ESTs and GSS in NCBI, of which 21 miRNA genes have not been previously reported. To prove their validity, five of the computationally predicted miRNAs were verified by RTPCR, their transcripts were successfully detected, and, 46 potential target genes for these miRNAs were predicted, most target genes encode transcription factors, they are involved in signal transduction, metabolism and development processes...|$|R
30|$|By {{targeting}} mRNAs for translational <b>repression</b> <b>or</b> <b>degradation,</b> miRNAs play important regulatory {{roles in}} animals and plants. As {{one of the}} most abundant classes of gene regulatory molecules in organisms, miRNAs likely influence the output of many protein-coding genes (Bartel 2004). There is mounting evidence to suggest that miRNAs are involved in many fundamental cellular processes such as cell differentiation, proliferation, apoptosis, carcinogenesis and cancer progression (Winter et al. 2009; Joshi et al. 2014). Correlated with characteristic clinicopathological parameters in cancer subtypes and existing not only in tissue but also in body fluids, microRNAs are potential biomarkers for different cancer subtypes classified by origin, histology, or chemosensitivity (Lu et al. 2005; Gilad et al. 2008; Kishikawa et al. 2015; Hollis et al. 2015). Due to their characteristic nature, microRNAs have a potential to be used for the development of diagnostics, prognostics, and targeted therapeutics.|$|E
40|$|International audienceINTRODUCTION: MicroRNAs (miRNAs) are an {{emerging}} group of small noncoding RNAs that regulate gene expression posttranscriptionally, by targeting messenger RNAs (mRNAs) for translational <b>repression</b> <b>or</b> <b>degradation.</b> They have roles in multiple facets of immunity, from regulation of cell development to activation and function in immune responses. Recent evidence underlines an involvement of miRNAs in {{the pathogenesis of}} autoimmune diseases as well as multiple sclerosis (MS). AREAS COVERED: In this review, the current knowledge of miRNA biogenesis, diverse roles of miRNAs in different cells that could {{be involved in the}} process of the disease, and their potential therapeutic applications are summarized. The authors searched MEDLINE and Science direct databases. EXPERT OPINION: The miRNAs in central nervous system lesions and peripheral blood are potential biomarkers for diagnostic and prognostic use. Also, miRNA mimics, small-molecule inhibitors of specific miRNAs, and antisense oligonucleotides could be therapeutic weapons that facilitate us to combat the disease...|$|E
40|$|MicroRNAs (miRNAs) mediate {{translational}} <b>repression</b> <b>or</b> <b>degradation</b> {{of their}} target messenger RNAs by RNA interference (RNAi). The primary transcripts of miRNA genes (pri-miRNAs) are sequentially processed by the nuclear Drosha–DGCR 8 complex to approximately 60 – 70 nucleotide (nt) intermediates (pre-miRNAs) {{and then by}} the cytoplasmic Dicer–TRBP complex to approximately 20 – 22 nt mature miRNAs. Certain pri-miRNAs are subject to RNA editing that converts adenosine to inosine (A → I RNA editing); however, the fate of edited pri-miRNAs is mostly unknown. Here, we provide evidence that RNA editing of pri-miR- 151 results in complete blockage of its cleavage by Dicer and accumulation of edited pre-miR- 151 RNAs. Our results indicate that A → I conversion at two specific positions of the pre-miRNA foldback structure can affect its interaction with the Dicer–TRBP complex, showing a new regulatory role of A → I RNA editing in miRNA biogenesis...|$|E
40|$|In cell senescence, {{cultured cells}} cease proliferating and acquire {{aberrant}} gene expression patterns. MicroRNAs (miRNAs) modulate gene expression through translational <b>repression</b> <b>or</b> mRNA <b>degradation</b> {{and have been}} implicated in senescence. We used deep sequencing {{to carry out a}} comprehensive survey of miRNA expression and involvement in cell senescence. Informatic analysis of small RNA sequence datasets from young and senescent IMR 90 human fibroblasts identifies many miRNAs that are regulated (either up or down) with cell senescence. Comparison with mRNA expression profiles reveals potential mRNA targets of these senescence-regulated miRNAs. The target mRNAs are enriched for genes involved in biological processes associated with cell senescence. This result greatly extends existing information on the role of miRNAs in cell senescence and is consistent with miRNAs having a causal role in the process...|$|R
40|$|MicroRNAs (miRNAs) {{are short}} RNA {{molecules}} (∼ 22 nt long) {{that act as}} gene regulators in many eukaryotes. By binding to complementary strands of messenger RNAs (mRNAs), they induce translational <b>repression</b> <b>or</b> target <b>degradation.</b> Since their discovery in 1993 (Lee et al., 1993), they have {{received a lot of}} attention in the research area and some thousands of miRNAs {{have been reported in the}} literature; version 18. 0 of miRBase (Kozomara and Griffiths-Jones, 2011) contains 18. 226 entries representing precursor miRNAs in 168 species, which express 21. 643 mature miRNA products. Each of these small RNA structures regulates many target mRNAs (Baek et al., 2008), while the detection of the targets is a great challenge for researchers. Besides the number of identified miRNAs that grows very fast, the experiments performe...|$|R
40|$|Abstract. MicroRNAs (miRNAs or miRs) are {{a family}} of small non-coding RNAs that {{regulate}} gene expression by the sequence-selective targeting of mRNAs, leading to translational <b>repression</b> <b>or</b> mRNA <b>degradation,</b> depending {{on the degree of}} complementarity with target mRNA sequences. miRNAs {{play a crucial role in}} cancer. In the case of breast tumors, several studies have demonstrated a correlation between: i) the expression profile of oncogenic miRNAs (oncomiRs) or tumor suppressor miRNAs and ii) the tumorigenic potential of triple-negative [estrogen receptor (ER), progesterone receptor (PR) and Her 2 / neu] primary breast cancers. Among the miRNAs involved in breast cancer, miR- 221 plays a crucial role for the following reasons: i) miR- 221 is significantly overexpressed in triple-negative primary breast cancers; ii) the oncosuppressor p 27 Kip 1, a validated miR- 221 target, is downregulated in aggressiv...|$|R
40|$|MicroRNAs are a {{class of}} small noncoding RNAs that {{function}} as critical gene regulators through targeting mRNAs for translational <b>repression</b> <b>or</b> <b>degradation.</b> In this study, we showed that miR- 128 expression levels were decreased in glioma, and identified p 70 S 6 K 1 as a novel direct target of miR- 128. Overexpression of miR- 128 suppressed p 70 S 6 K 1 and its downstream signaling molecules such as HIF- 1 and VEGF expression, and attenuated cell proliferation, tumor growth and angiogenesis. Forced expression of p 70 S 6 K 1 can partly rescue the inhibitory effect of miR- 128 in the cells. Taken together, these findings will shed light to the role and mechanism of miR- 128 in regulating glioma tumor angiogenesis via miR- 128 / p 70 S 6 K 1 axis, and miR- 128 {{may serve as a}} potential therapeutic target in glioma in the future...|$|E
40|$|Lung {{cancer is}} the leading cause of cancer death in men and women worldwide. The lack of {{specific}} and sensitive tools for early diagnosis as well as still-inadequate targeted therapies contribute to poor outcomes. MicroRNAs are small non-coding RNAs, which regulate gene expression post-transcriptionally by translational <b>repression</b> <b>or</b> <b>degradation</b> of target mRNAs. A growing body of evidence suggests various roles of microRNAs including development and progression of lung cancer. In lung cancer, several studies have showed that certain microRNA profiles classified lung cancer subtypes, and that specific microRNA expression signatures distinguished between better-prognosis and worse-prognosis lung cancers. Furthermore, microRNAs circulate in body fluids, and therefore may serve as promising biomarkers for early diagnosis of lung cancer as well as for predicting prognosis of patients. In the present review, we briefly summarize microRNAs in the development and progression of lung cancer, focusing on possible applications of microRNAs as novel biomarkers and tools for treatment...|$|E
40|$|MicroRNAs (miRNAs) {{are members}} of the small non-coding RNAs, which are principally known for their {{functions}} as post-transcriptional regulators of target genes. Regulation by miRNAs is triggered by the translational <b>repression</b> <b>or</b> <b>degradation</b> of their complementary target messenger RNAs (mRNAs). The growing number of reported miRNAs and the estimate that hundreds or thousands of genes are regulated by them suggest a magnificent gene regulatory network in which these molecules are embedded. Indeed, recent reports have suggested critical roles for miRNAs in various biological functions, such as cell differentiation, development, oncogenesis, and the immune responses, which are mediated by systems-wide changes in gene expression　profiles. Therefore, it is essential to analyse this complex regulatory network at the transcriptome and proteome levels, which should be possible with approaches that include both high-throughput experiments and computational methodologies. Here, we introduce several systems-level approaches that have been applied to miRNA research, and discuss their potential to reveal miRNA-guided gene regulatory systems and their impacts on biological functions...|$|E
40|$|MicroRNAs (miRNAs) are a {{class of}} small noncoding RNAs that control gene {{expression}} by targeting mRNAs and triggering either translation <b>repression</b> <b>or</b> RNA <b>degradation.</b> Their aberrant expression {{may be involved in}} human diseases, including cancer. Indeed, miRNA aberrant expression has been previously found in human chronic lymphocytic leukemias, where miRNA signatures were associated with specific clinicobiological features. Here, we show that, compared with normal breast tissue, miRNAs are also aberrantly expressed in human breast cancer. The overall miRNA expression could clearly separate normal versus cancer tissues, with the most significantly deregulated miRNAs being mir- 125 b, mir- 145, mir- 21, and mir- 155. Results were confirmed by microarray and Northern blot analyses. We could identify miRNAs whose expression was correlated with specific breast cancer biopathologic features, such as estrogen and progesterone receptor expression, tumor stage, vascular invasion, or proliferation index...|$|R
40|$|MicroRNAs (miRNAs) are a {{class of}} short non-coding RNAs that {{primarily}} regulate protein synthesis through reversible translational <b>repression</b> <b>or</b> mRNA <b>degradation.</b> MiRNAs can act by translational control of transcription factors or via direct action on the chromatin, and thereby contribute to the non-genetic control of gene–environment interactions. MiRNAs that regulate components of pathways required for learning and memory further modulate the influence of epigenetics on cognition in the normal and diseased brain. This review summarizes recent data exemplifying the known roles of miRNAs in memory formation in different model organisms, and describes how neuronal plasticity regulates miRNA biogenesis, activity and degradation. It also examines the relevance of miRNAs for memory impairment in human, using recent clinical observations related to neurodevelopmental and neurodegenerative diseases, and discusses the potential mechanisms by which these miRNAs may contribute to memory disorders. This article {{is part of the}} Special Issue entitled ‘Neuroepigenetic Disorders’...|$|R
40|$|MicroRNAs (miRs) are {{a family}} of small noncoding RNAs that {{regulate}} gene expression by targeting mRNAs in a sequence specific manner, inducing translational <b>repression</b> <b>or</b> mRNA <b>degradation.</b> In this paper we have first analyzed by microarray the miR-profile in erythroid precursor cells from one normal and two thalassemic patients expressing different levels of fetal hemoglobin (one of them displaying HPFH phenotype). The microarray data were confirmed by RT-PCR analysis, and allowed us to identify miR- 210 as an highly expressed miR in the erythroid precursor cells from the HPFH patient. When RT-PCR was performed on mithramycin-induced K 562 cells and erythroid precursor cells, miR- 210 {{was found to be}} induced in time-dependent and dose-dependent fashion, together with increased expression of the fetal gamma-globin genes. Altogether, the data suggest that miR- 210 might be involved in increased expression of gamma-globin genes in differentiating erythroid cells...|$|R
40|$|Micro-RNAs (miRNAs) {{are short}} (average 22 nucleotides) noncoding {{regulatory}} RNAs that inhibit gene expression by targeting complementary 3 ′-untranslated regions of protein-encoding mRNAs for translational <b>repression</b> <b>or</b> <b>degradation.</b> miRNAs play key roles {{in both the}} function and differentiation of many cell types. Drosha and Dicer, two RNAase III enzymes, function in a stepwise manner to generate a mature miRNA. Previous {{studies have shown that}} podocyte-specific deletion of Dicer during development results in proteinuric renal disease and collapsing glomerulopathy (CG); however, Dicer has functions other than the generation of miRNAs. Here we found that the podocyte-specific deletion of Drosha results in a similar phenotype to Dicer mutants, confirming that the Dicer mutant phenotype is due to the loss of miRNAs. Moreover, the inducible deletion of Drosha in 2 - to 3 -month-old mice (Tet-On system) resulted in CG. Thus, continuous generation of miRNAs are required for the normal function of mature podocytes and their loss leads to CG. Identifying these miRNAs may provide new insight into disease pathogenesis and novel therapeutic targets in various podocytopathies...|$|E
40|$|MicroRNAs, non-coding 20 - 22 {{nucleotide}} single-stranded RNAs, {{result in}} translational <b>repression</b> <b>or</b> <b>degradation</b> and gene silencing of their target genes, and significantly {{contribute to the}} regulation of gene expression. In the current study, we report that miR- 182 expression was significantly upregulated in prostate cancer tissues and four cell lines, compared to benign prostatic hyperplasia tissues and normal prostatic epithelial (RWPE- 1) cells. Ectopic overexpression of miR- 182 significantly promotes the proliferation, increases the invasion, promotes the G 1 /S cell cycle transition and reduces early apotosis of PC- 3 cells, while suppression of miR- 182 decreased the proliferation and invasion, inhibits the G 1 /S cell cycle transition and increase early apotosis of PC- 3 cells. Additionally, we demonstrated that miR- 182 could downregulate expression of NDRG 1 by directly targeting the NDRG 1 3 '-untranslated region. In conclusion, our results suggest that miR- 182 {{plays an important role}} in the proliferation of human prostate cancer cells by directly suppressing the tumor supressor gene NDRG 1. We uncovered a new epigenetic regulation of NDRG 1...|$|E
40|$|Nonalcoholic {{fatty liver}} disease (NAFLD) {{has become the}} most common liver disorder. Strongly linked to obesity and diabetes, NAFLD has the {{characteristics}} of complex diseases with substantial heterogeneity. Accordingly, our ability to predict the risk of advanced NAFLD and provide efficient treatment may improve by {{a better understanding of the}} relationship between genotype and phenotype. MicroRNAs (miRNAs) play a major role in the fine-tuning of gene expression and they have recently emerged as novel biomarkers and therapeutic tools in the management of NAFLD. These short non-coding RNA sequences act by partial <b>repression</b> <b>or</b> <b>degradation</b> of targeted mRNAs. Deregulation of miRNAs has been associated with different stages of NAFLD, while their biological role in the pathogenesis remains to be fully understood. Systems biology analyses based on predicted target genes have associated hepatic miRNAs with molecular pathways involved in NAFLD progression such as cholesterol and lipid metabolism, insulin signaling, oxidative stress, inflammation, and pathways of cell survival and proliferation. Moreover, circulating miRNAs have been identified as promising noninvasive biomarkers of NAFLD and linked to disease severity. This rapidly growing field is likely to result in major advances in the pathomechanism, prognostication, and treatment of NAFLD...|$|E
40|$|Peptide {{nucleic acids}} (PNAs) are DNA/RNA mimics {{extensively}} used for pharmacological regulation of gene expression {{in a variety}} of cellular and molecular systems, and they have been described as excellent candidates for antisense and antigene therapies. At present, very few data are available on the use of PNAs as molecules targeting miRNAs. miRNAs are a family of small nc RNAs that regulate gene expression by sequence-selective targeting of mRNAs, leading to a translational <b>repression</b> <b>or</b> mRNA <b>degradation</b> to the control of highly regulated biological functions, such as differentiation, cell cycle and apoptosis. The aim {{of this article is to}} present the state-of-the-art concerning the possible use of PNAs to target miRNAs and modify their biological metabolism within the cells. The results present in the literature allow to propose PNA-based molecules as very promising reagents to modulate the biological activity of miRNAs. In consideration of the involvement of miRNAs in human pathologies, PNA-mediated targeting of miRNAs has been proposed as a potential novel therapeutic approach...|$|R
40|$|PS 1 -M 146 V {{transgenic}} AD mice, {{and that}} this upre-(Delay et al., 2012). miRNA precursors are first processed into 0 and PS 1 -M 146 V mouse hippocampal neurons, miR- 342 - 5 p, a miRNA that targets AnkG mRNA 30 UTR, is highly upregulatedence of senile plaques and neurofibrillary tangles (Price et al., 1995), together with axonal pathology involving dystrophic neurites decorating amyloid plaques, axonal swellings, and embryonic day 14 (E 14). Our data showed that, with the criterion of a 2 -fold cutoff, seven miRNAs were upregulated (Figure 1 A, red dots) and seven miRNAs were downregulated (green dots) abnormal accumulation of axonal proteins (Bayer et al., 2001). Axonopathy and axonal transport deficits {{have been found in}} in APP/PS 1 hippocampal tissues as compared with WT hippo-campal tissues. Among these altered miRNAs, miR- 342 - 5 pa single-stranded miRNA that interacts with the 3 UTR of the complementary mRNA sequences (Peters and Meister, 2007), resulting in translation <b>repression</b> <b>or</b> target <b>degradation</b> (Eulali...|$|R
40|$|MicroRNAs (miRNAs) are a {{class of}} small noncoding RNAs that can {{regulate}} gene expression by binding to target mRNAs and induce translation <b>repression</b> <b>or</b> RNA <b>degradation.</b> 				There have been many studies indicating that both miRNAs and mRNAs display aberrant expression in breast cancer. 				Previously, most researches into the molecular mechanism of breast cancer examined miRNA expression patterns and mRNA expression patterns separately. 				In this study, we systematically analysed miRNA-mRNA paired variations (MMPVs), 				which are miRNA-mRNA pairs whose pattern of regulation can vary in association with biopathological features, such as the oestrogen receptor (ER), 				TP 53 and human epidermal growth factor receptor 2 (HER 2) genes, survival time, and breast cancer subtypes. 				We demonstrated {{that the existence of}} MMPVs is general and widespread but that there is a general unbalance in the distribution of MMPVs among the different biopathological features. 				Furthermore, based on studying MMPVs that are related to multiple biopathological features, we propose a potential crosstalk mechanism between ER and HER 2...|$|R
40|$|Osteosarcoma is {{the most}} common type of primary tumor of bone which mainly affects {{adolescents}} and young adults. Osteosarcoma causes large number of deaths because of its complex pathogenesis and resistance to conventional treatment. MicroRNAs are a class of small noncoding RNAs that function as critical gene regulators through targeting mRNAs, causing translational <b>repression</b> <b>or</b> <b>degradation.</b> In this study, we showed that miR- 217 was down-regulated in osteosarcoma cell lines and tissues in comparison to that in normal bone cells or tissues. Meanwhile, the lower level of miR- 217 was associated with metastasis in clinical osteosarcoma patients. Furthermore, we found that overexpession of miR- 217 markedly suppressed cell proliferation, migration, and invasion of osteosarcoma cells. Conversely, the inhibition of miR- 217 expression significantly accelerated the cell proliferation, migration, and invasion. Moreover, we identified WASF 3 as a novel functional downstream target of miR- 217. The ectopic expression of WASF 3 can partially reverse the inhibition of cell proliferation and invasion caused by miR- 217. Take together, our results demonstrate that miR- 217 functions as a tumor-suppressive miRNA and inhibits the osteosarcoma tumorigenesis through targeting WASF 3...|$|E
40|$|MicroRNAs (miRNAs) are ~ 22 nt long single-strand RNA {{found in}} all groups of organisms, where they affect biochemical, {{physiological}} and behavioral pathways by regulation of protein expression. Regulation of protein expression is mediated by silencing mRNA of target genes {{in one of two}} processes, translation <b>repression</b> <b>or</b> <b>degradation</b> of mRNA. Changed expression of miRNA can lead to aberrant regulatory pathways resulting in various pathophysiological conditions like cardiovascular diseases, cancer or neurological disorders. MiRNA can play a role in cancer both as an oncogen or as a tumor suppressor, and it is tissue and cancer-type specific. In colorectal cancer miRNAs downregulate or upregulate signaling pathways including key processes involved in cancer development, like proliferation, cell cycle, apoptosis and metastasis formation. Circadian clock in mammals synchronizes cellular and physiological processes by transcriptional-translational feedback loops. Not only miRNAs regulate the levels of key clock genes and clock controlled genes, but also a number of miRNAs exhibit circadian expression. Therefore aberrant circadian rhythms increase risk of colorectal cancer also by altered expression of miRNAs. The main aim of the thesis was to identify miRNAs, which regulate both tumorigenesis and circadian [...] ...|$|E
40|$|MicroRNAs are a {{class of}} small, noncoding RNAs that {{function}} as critical regulators of gene expression by targeting mRNAs for translational <b>repression</b> <b>or</b> <b>degradation.</b> In this study, we demonstrate that expression of microRNA- 124 (miR- 124) is significantly downregulated in colorectal cancer tissues and cell lines, compared to the matched adjacent tissues. We identified and confirmed inhibitor of apoptosis-stimulating protein of p 53 (iASPP) as a novel, direct target of miR- 124 using target prediction algorithms and luciferase reporter gene assays. Overexpression of miR- 124 suppressed iASPP protein expression, upregulated expression of the downstream signaling molecule nuclear factor-kappa B (NF-κB), and attenuated cell viability, proliferation, and colony formation in SW 480 and HT- 29 colorectal cancer cells in vitro. Forced overexpression of iASPP partly rescued the inhibitory effect of miR- 124 on SW 480 and HT 29 cell proliferation. Taken together, these findings {{shed light on the}} role and mechanism of action of miR- 124, indicate that the miR- 124 /iASPP axis can regulate the proliferation of colorectal cancer cells, and suggest that miR- 124 may serve as a potential therapeutic target for colorectal cancer...|$|E
30|$|MicroRNAs (miRNAs) are 21 – 23 {{nucleotides}} noncoding RNAs {{that regulate}} {{the expression of}} messenger RNAs. miRNA-mediated gene silencing plays important roles {{in a variety of}} biological processes (Flynt and Lai, 2008; Jonas and Izaurralde, 2015). miRNAs in complex with Argonaute proteins (Ago 1 – 4) bind to target mRNAs through nucleotide pairing and recruit one of the TNRC 6 proteins (TNRC 6 A- 6 C) to form the RNA-induced silencing complex (RISC) (Pfaff and Meister, 2013). RISC can promote target mRNA translation <b>repression,</b> <b>degradation</b> <b>or</b> both (Fabian et al., 2010).|$|R
40|$|Abstract Background MicroRNAs (miRNAs) are a {{class of}} small non-coding RNAs that {{regulate}} gene expression by targeting mRNAs for translation <b>repression</b> <b>or</b> mRNA <b>degradation.</b> Although many miRNAs have been discovered and studied in human and mouse, few studies focused on porcine miRNAs, especially in genome wide. Results Here, we adopted computational approaches including support vector machine (SVM) and homology searching to make a global scanning on the pre-miRNAs of pigs. In our study, we built the SVM-based porcine pre-miRNAs classifier with a sensitivity of 100 %, a specificity of 91. 2 % and a total prediction accuracy of 95. 6 %, respectively. Moreover, 2204 novel porcine pre-miRNA candidates were found by using SVM-based pre-miRNAs classifier. Besides, 116 porcine pre-miRNA candidates were detected by homology searching. Conclusions We identified the porcine pre-miRNA in genome-wide through computational approaches by utilizing the data sets of pigs {{and set up the}} porcine pre-miRNAs library which may provide us a global scanning on the pre-miRNAs of pigs in genome level and would benefit subsequent experimental research on porcine miRNA functional and expression analysis. </p...|$|R
40|$|Vertebrate muscle {{differentiation}} is {{coordinated by}} an intricate network of transcription factors requiring proliferating myogenic precursors to withdraw irreversibly from the cell cycle. Recent studies have implicated {{a large number}} of microRNAs exerting another layer of control in many aspects of muscle differentiation. By annealing to short recognition sequences in the 3 ′-untranslated region, microRNAs attenuate target gene expression through translation <b>repression</b> <b>or</b> mRNA <b>degradation.</b> Here, we show that miR- 214 promotes myogenic differentiation in mouse C 2 C 12 myoblasts at a step preceding the induction of p 21 and myogenin. Blocking miR- 214 function with a 2 ′-O-methylated double-stranded inhibitor maintained C 2 C 12 cells in the active cell cycle, thereby inhibiting the myogenic differentiation. By global gene expression profiling, we identified the proto-oncogene N-ras as one of miR- 214 targets. Furthermore, manipulating the N-Ras level with small interfering RNA or adenovirus-mediated forced expression either augmented or attenuated the effect of miR- 214, respectively. Thus, our data uncovered a novel microRNA-mediated mechanism that controls myogenic differentiation...|$|R
